Blunted nighttime blood pressure (BP) dipping, typically defined as b10% fall in average BP from daytime to nighttime, is a strong prognostic indicator of cardiovascular morbidity and mortality for both hypertensive and nonhypertensive individuals. [1] [2] [3] [4] Blunted nighttime BP dipping also appears to be unusually common in patients with coronary heart disease (CHD), with a nondipping pattern approximately twice as common as in age-matched controls. [5] [6] [7] For vulnerable CHD patients, blunted nighttime BP dipping may exacerbate their heightened risk of adverse cardiovascular disease (CVD) events. As a result, there have been a number of different approaches designed to enhance BP dipping in various CVD populations.
Chronotherapy is one successful approach to enhancing nighttime BP dipping. For patients with hypertension, bedtime dosing of antihypertensive medications, rather than typical morning dosing, lowers nighttime BP. [8] [9] [10] Nighttime dosing of melatonin, a hormone involved in diurnal regulation, may also enhance BP dipping through multiple physiological pathways. 11 Lifestyle factors including physical activity and psychological stress also affect the nocturnal decline in BP. For example, greater daytime physical activity has been related to enhanced nighttime BP dipping, 12 but the evidence is equivocal with regard to whether dipping is improved with exercise (EX) training. [13] [14] [15] [16] Psychological stress has also been linked to a blunted fall in nighttime BP, 17 suggesting that behavioral interventions designed to reduce stress may also enhance dipping.
However, to our knowledge, no study to date has evaluated whether stress reduction may improve BP dipping in CHD patients. The present report from the Smart Heart trial 18 examined the effects of a 16-week stress management (SM) intervention and aerobic EX compared with usual care (UC) on nighttime BP dipping in patients with CHD. The primary results of the trial, which showed that both active interventions improved biomarkers of cardiovascular risk, have been reported previously. 18 To assess BP dipping, 24-hour ambulatory blood pressure monitoring (ABPM) was performed before and after the interventions. We hypothesized that both EX and SM would result in enhanced nighttime BP dipping compared with UC.
Methods

Study design
This is a secondary analysis of the Smart Heart trial of 134 patients with CHD and EX-induced myocardial ischemia. Primary outcomes, including stress-induced myocardial ischemia, CVD biomarkers, and measures of general distress have been reported previously. 19 This report focuses on 24-hour ABPM data that have not been reported previously. The study was conducted from January 1999 through February 2003. The study was supported by grants HL59672 and M01-RR-30 from the National Institutes of Health. The authors are solely responsible for the design and conduct of this study, all study analyses, and the drafting and editing of the paper and its final contents.
Participants
The patient sample consisted of 134 patients (92 male; 42 female), age 40 to 84 years (mean age 62 ± 10 years), with documented CHD, and evidence of EX-induced myocardial ischemia. This study was approved by the institutional review board at Duke University Medical Center and written informed consent was obtained from all participants before their participation.
Procedures
Twenty-four hour ambulatory blood pressure monitoring. Ambulatory blood pressure monitoring was conducted during a typical workday. The AccuTracker II ABP Monitor (Suntech, Raleigh, NC) was worn for approximately 24 hours, usually starting between 8 AM and 10 AM until the same time the after morning. The AccuTracker II, which measures BP noninvasively based on the auscultatory technique, has been validated for accuracy. [20] [21] [22] It was programmed to take 3 BP measurements per hour at random intervals during daytime hours, and 2 readings per hour during the participant's anticipated nighttime sleep period. Participants were instructed to follow their normal daily schedule. Mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) values were computed based on all valid readings obtained during waking hours and during nighttime sleep (defined by the participants' retrospective reports of when they turned out room lights at bedtime to the time they got out of bed the following morning). The SBP and DBP dipping were computed as continuous variables, defined as percent change from mean waking BP to mean nighttime sleep BP.
Medications. Because the focus of the parent trial 18 was on mental stress-induced myocardial ischemia, unless medically contraindicated, patients discontinued their use of anti-ischemic medications, including β-blockers, calcium-channel blockers, and long-lasting nitrates for 48 hours before their baseline and postintervention ABPM assessments. Twenty-eight participants could not safely discontinue their anti-ischemic medications, and those that did discontinue them did so for ≤3 days. Most participants were taking a daily low-dose aspirin and lipid-lowering drugs. There were no group differences in medication usage, which was described in detail in the primary publication.
18
Interventions. Once patients completed their baseline ABPM assessments, they resumed their usual medical management on anti-ischemic medications. Importantly, participants were taking the same medications for their baseline and postintervention 24-hour ABPM study. Using block randomization, patients were randomly assigned to 1 of 3 treatment conditions. Exercise training. Patients assigned to the aerobic EX condition exercised 3 times per week for 16 consecutive weeks. The EX sessions consisted of a 10 minute warm-up period involving stretching and EX on a stationary bicycle at a heart rate of 50% to 70% heart rate reserve followed by 35 minutes of walking and jogging at a target intensity of 70% to 85% heart rate reserve. Stress management training. The SM training program was based upon our prior work, 23 which emphasizes a cognitive-social learning model of behavior. The interaction of the social environment with personality traits that predispose individuals to respond to situations in particular ways was highlighted, and the treatment program was based upon the notion that emotion and behavior are largely determined by individuals' cognitive perceptions. The program consisted of 16 weekly 1.5-hour sessions conducted in a group setting with 6 to 8 patients per group. Three key components of the intervention included education, coping skills training, and social support. Participants were provided information about CHD, the structure and function of the heart, traditional risk factors, and emotional stress. Stress was considered to be an imbalance between excessive demands and inadequate coping skills. The coping skills training aspect of the intervention included instruction in specific skills to reduce the affective, behavioral, cognitive, and physiological components of stress. Therapeutic techniques included graded task assignments, monitoring irrational automatic thoughts, and generating alternative interpretations of situations or unrealistic thought patterns.
Patients were instructed in progressive muscle relaxation and imagery techniques, along with training in assertiveness, problem solving, and time management. Role playing was also used. Finally, group interaction and social support were encouraged. Usual care. Patients in the UC condition were monitored on a monthly basis to ensure that they had not joined any EX or SM training program. Patients were maintained on their regular medical regimens and saw their local cardiologists as needed. No attempt was made, in any way, to alter the UC that these patients received from their personal physicians.
Statistical analysis
Treatment group effects for BP dipping were evaluated using general linear models through SAS 9.2 (PROC GLM, SAS Institute, Cary, NC). All models included prerandomization baseline values of the outcome variable, gender, and ethnicity. Analyses of treatment effects followed the intention-to-treat principle, with posttreatment missing data managed using Markov chain Monte Carlo multiple imputation methods available in SAS (PROC MI) and 1,000 imputations. Planned, orthogonal contrasts were conducted comparing (1) both active treatment groups (EX and SM) vs UC and (2) the EX and SM groups. We evaluated the extent to which models met assumptions, including additivity, linearity, and distribution of residuals. We found no evidence of significant violations of these assumptions.
Results
One hundred thirty-four individuals were randomized to participate in the intervention including 44 to SM, 48 to EX, and 42 to UC, as previously reported (Table I) . 18 The flow of participants from recruitment through postintervention assessments is illustrated in Figure 1 .
We did not observe any baseline imbalance in daytime or nighttime ambulatory BPs (all P N .774), SBP dipping (P = .853), or DBP dipping (P = .951). At baseline, 124 participants provided BP dipping data. Of these, 64 (52%) were considered "dippers" (≥10% mean SBP dip from daytime to nighttime).
Nocturnal blood pressure dipping changes
Examination of planned treatment contrasts demonstrated that the EX and SM groups exhibited a strong trend toward greater improvements in SBP dipping compared with the UC condition (P = .052). The SBP dipping improvements from pretreatment to posttreatment were 3.2% (SE = 1.5) for SM, 1.7% (SE = 1.5) for EX, and −0.7% (SE = 1.4) for UC (Table II) . As shown in Figure 2 , this corresponded to mean posttreatment SBP dipping values of 12.9% (SE = 1.5) for SM, 11.1% (SE = 1.4) for EX, and 8.6% (SE = 1.4) for UC.
Examination of changes in DBP dipping demonstrated a similar pattern of findings, with the treatment groups demonstrating greater improvements in DBP dipping compared with the UC condition (P = .031). The DBP dipping improvements from pretreatment to posttreatment were 1.2% (SE = 1.9) for SM, 2.5% (SE = 1.9) for EX, and −3.0% (SE = 1.8) for UC, corresponding to mean posttreatment DBP dipping values of 13.2% (SE = 1.9) for SM, 14.0% (SE = 1.9) for EX, and 8.8% (SE = 1.8) for UC ( Figure 2 ; Table II) .
Daytime blood pressure changes
Examination of average daytime SBP revealed no overall change from baseline to postintervention (P = .272), and treatment groups did not differ after the interventions (P = .673), with posttreatment values of 131.1 (1.7) mm Hg for SM, 130.5 (1.7) mm Hg for EX, and 130.1 (1.6) mm Hg for UC. A similar nonsignificant pattern was noted for DBP (P = .887), with posttreatment daytime DBP values of 74.6 (1.0) mm Hg for SM, 73.9 (0.9) mm Hg for EX, and 74.6 (0.9) mm Hg for UC (Table II) .
Nighttime blood pressure changes
Examination of mean nighttime SBP revealed that treatment groups did not differ significantly after (Table II) .
Discussion
Few studies have examined nighttime BP dipping in patients with CHD. Mousa et al 5 first described this phenomenon in a study of 68 men with documented CHD who exhibited a significantly blunted nighttime BP dipping compared with 68 age-matched healthy men. Our prior work described similar findings in a study comparing 54 postmenopausal women with documented CHD with 48 age-matched control women. 6 Most recently, in a study of 401 patients with CVD, including those with CHD and others who had experienced an ischemic stroke, Cai et al 7 reported that blunted nighttime BP dipping was related to greater risk of a cardiovascular event. The present study provides further evidence that patients with CHD are prone to exhibit a nondipping nighttime BP pattern, potentially placing them at higher risk for adverse CVD events. In this sample, almost half of participants were considered "nondippers" (≥10% mean SBP dip from daytime to nighttime). The present findings also demonstrate that 2 behavioral interventions, EX and SM training, may augment nighttime BP dipping, which may help reduce the risk of adverse CVD events associated with blunted BP dipping.
Because sleep quality is directly related to the magnitude of nighttime BP dipping, 6,24-26 1 mechanism by which both the EX and SM training interventions may have enhanced BP dipping is by improving sleep quality. This possibility is supported by our finding that augmentation of nighttime BP dipping was achieved through postintervention declines in nighttime BP, with little changing in daytime BP. No clinical trials have evaluated the effects of sleep medications on nighttime BP dipping. Nighttime dosing of melatonin, however, a hormone involved in diurnal regulation, appears to enhance nighttime BP dipping, possibly in part by improving sleep quality. 11 Stress is considered to be one of the most common causes of insomnia, 27 and EX training may be an effective treatment for insomnia in a variety of patient populations. [28] [29] [30] As previously reported, participants in the present study who underwent SM or EX training showed a reduction in psychological distress, 18 which may have had a beneficial effects on their sleep quality.
These findings provide further evidence for the value of SM and EX training in improving cardiovascular health, and support previous reports that increased levels of physical activity may benefit BP dipping. [14] [15] [16] The mechanisms by which EX may promote lower nighttime BP and augmented BP dipping have yet to be elucidated. Both EX and SM training have been shown to produce favorable changes in physiological regulatory systems, including improved vascular endothelial vasodilatory function. 19 Interestingly, impaired endothelial function has been linked both to nighttime hypertension and insomnia. 31, 32 Although EX did not result in improved heart rate variability (HRV) measured during supine deep breathing, SM training did improve HRV compared with UC. 19 Reduced HRV is indicative of low parasympathetic activity, and has been associated with blunted nighttime BP dipping. 33 In contrast, reduced resting sympathetic activity is related to enhanced nighttime BP dipping. 24, 26, 34 The present study has several limitations. These include a relatively small sample size for a clinical trial that was not powered specifically to examine the effects of EX and SM training on nighttime BP dipping. Due in part to the sample size limitation, the study was not designed to address mechanisms responsible for intervention effects on BP dipping. Nonetheless, our observations suggest that over the course of 16 weeks, 2 behavioral interventions, EX and SM training, can enhance nighttime BP dipping in CHD patients, who are both prone to exhibit blunted dipping and are at heightened risk of adverse clinical events.
Enhancing nocturnal BP dipping by pharmacological chronotherapy has been shown to reduce subsequent cardiovascular events. 9 A small substudy of the HOPE trial first showed that nighttime dosing of ramipril reduced cardiovascular morbidity and mortality in patients with peripheral arterial disease. 35 The MAPEC trial subsequently provided compelling evidence that in patients with hypertension, restoration of a normal nighttime "dipper" profile reduced the risk of CVD, stroke and new onset diabetes. 36 Nighttime dosing of antihypertensive medications typically augments BP dipping by lowering nighttime BP. Compared with UC controls, this same phenomenon was evident for DBP dipping for the behavioral interventions. Because both EX and SM training improved other biomarkers of CVD risk, in addition to nighttime BP dipping, and also reduced psychological distress, these behavioral interventions also should reduce the risk for worse CHD outcomes. 18 For EX training, the supportive evidence is already compelling, and recent evidence indicates that enhancing traditional cardiac rehabilitation with SM training can further reduce risk of adverse clinical events in cardiac patients. 37 
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Figure 2
Postintervention nighttime SBP and DBP dipping (%) after 16 weeks of EX training, SM training, and UC. 
